Arcadia Biosciences, Inc. (RKDA)

Market Cap	3.53M
Revenue (ttm)	5.18M
Net Income (ttm)	-5.83M
Shares Out	1.36M
EPS (ttm)	-4.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,367
Open	2.630
Previous Close	2.650
Day's Range	2.585 - 2.630
52-Week Range	1.851 - 5.340
Beta	1.27
Analysts	Strong Buy
Price Target	6.00 (+131.39%)
Earnings Date	Nov 12, 2024

About RKDA

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

• Industry: Packaged Foods
• Sector: Consumer Staples
• IPO Date: May 15, 2015
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: RKDA
• Website: https://www.arcadiabio.com

Financial Performance

In 2023, Arcadia Biosciences's revenue was $5.33 million, a decrease of -28.15% compared to the previous year's $7.42 million. Losses were -$13.98 million, -9.07% less than in 2022.

Analyst Forecast

According to one analyst, the rating for RKDA stock is "Strong Buy" and the 12-month stock price forecast is $6.0.

Price Target

$6.0

(131.39% upside)

Analyst Consensus: Strong Buy